CluePoints Named 2019 “Trend Gazelles” by Home Methodology Regional National Benefits Partners
CluePoints is delighted to have been honoured in the Home Methodology Regional National Benefits Partners Trend Gazelle Awards 2019. For 18 years, the Trends editorial department has selected 200 Trends Gazelles. Trends Gazelles are fast-growing companies that form an integral part of our economic landscape. All of them competitive companies that positively influence the business climate in their region. They are sources of innovation and employment that are an inspiring role model for other companies.
CluePoints Wins “Best Risk-Based Monitoring” Solution in 2018 Biotechnology Awards
The Biotechnology Awards recognize the key players and companies that are driving the industry forward with game-changing advances and revolutionary developments. It celebrates the products, services, and solutions carried out around the world over the previous 12 months, selected by an international judging panel of individuals from a myriad of fields such as business, media, and journalism.
CluePoints’ ability to listen to the needs of the industry was a key factor in the company’s successful entry. A prime example is the annual User Group Meeting conducted in April, where clients are invited to discuss their thoughts and ideas. This empowers customers to play a key part in both shaping the future of the CluePoints solution as well as continuing to innovate and deliver new products and enhancements that will drive compliance, accelerate drug development, improve data quality and achieve cost and resource efficiencies.
CluePoints Founder Named One of Life Sciences Most Inspiring People by PharmaVOICE
PharmaVoice: Congratulations to CluePoints founder, Dr. Marc Buyse, on being recognized in this year’s PharmaVOICE 100! With thousands of nominations to consider, Marc, the “Savvy Statistician”, was chosen for his innovative and entrepreneurial spirit, applying statistical research to real-world problems and demonstrating the value of statistics in medical research.
CluePoints CEO, Francois Torche Honoured by PharmaVOICE
CluePoints’ CEO, François Torche, has been selected by PharmaVOICE as one of the top 100 most influential people in the life-sciences industry. François was recognized for his pivotal role in developing and promoting Central Statistical Monitoring (CSM), a ground-breaking concept that is transforming the assessment of data quality in clinical trials.
CluePoints Chief Commercial Officer Named in PharmaVOICE Top 100 Most Inspiring People in the Life Sciences Industry
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials, has today announced that its Chief Commercial Officer, Patrick Hughes, has been honored by PharmaVOICE as one of the 100 most inspiring people in the life sciences industry. Patrick was recognized for his pioneering work in risk-based monitoring (RBM) and dedication to challenging the industry’s traditional practices and processes when it comes to data analysis in clinical trials.
CluePoints Wins ENTENTE Life Science Investment Forum Award
The Entente award program, which is part of the European Venture Summit, acknowledged CluePoints for its Central Statistical Monitoring (CSM) solution that employs unique statistical algorithms to determine the quality, accuracy and integrity of clinical trial data. The win represents the second industry award that CluePoints has secured this month after the company’s risk-based monitoring solution was also recognized by the Scrip Awards.
CluePoints Wins Scrip Award for Best Technological Development in Clinical Trials
CluePoints was honoured with the award for the ‘Best Technological Development in Clinical Trials’ at the 2014 Scrip Awards held at The Lancaster Hotel, London on 3 December. The award, sponsored by the MCT Congress, recognizes ‘CluePoints in the Cloud’ as the ultimate quality oversight and risk-based monitoring (RBM) application developed to determine the quality and integrity of clinical trials data.